Ofloxacin versus parenteral therapy for chronic osteomyelitis.
We conducted a randomized comparison of oral ofloxacin (400 mg twice a day) and parenteral agents (cefazolin, 1.0 g intravenously every 8 h, or ceftazidime, 2.0 g intravenously every 12 h) in biopsy-confirmed, nonprosthesis osteomyelitis. A total of 19 subjects received ofloxacin for an average of 8...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1991
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245046/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2039205/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.3.538 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|